Abstract

Background: Breast cancer is extensively studied for its resistance to chemotherapy. Therefore, finding efficient therapeutic agents is vital to increasing the survival rate of patients. Objective: Here, we conducted an in vitro study on the anti-tumor properties of Vinca herbacea extract on SKBR3 cells. Methods: Apoptotic and anti-invasive activity of V. herbacea extract was studied using Annexin FITC-V kit and Matrigel invasive assay, respectively. The expression of angiogenesis genes (VEGFR-1, VEGFR-2, and VEGF-A), apoptotic-related genes (Bcl-2 and BAX), as well as metastatic genes (MMP2 and MMP9) were studied using real-time polymerase chain reaction. Results: Vinca herbacea extract showed significant antiproliferative and cytotoxic effects on human breast cancer cells, compared to human embryonic kidney cells 293. Vinca herbacea extract had a great apoptosis-inducing potential in breast cancer cells by activating caspase-3 and increasing the BAX/Bcl-2 ratio. Vinca herbacea extract prevented cancer cell angiogenesis, marked by decreasing the expression level of angiogenesis-related genes, including VEGF, VEGFR-1, and VEGFR-2. In addition, V. herbacea extracts reduced cancer cell invasion and noticeably decreased the expression level of metastasis-associated genes, including MMP2 and MMP9. Conclusion: Vinca herbacea extracts exhibited vigorous cytotoxic effects on SKBR3 cells by the alteration of apoptosis, cell adhesion, invasion, and angiogenesis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call